Clinical Trial Details
| Trial ID: | L4704 |
| Source ID: | NCT03486964 |
| Associated Drug: | Dpp-4 Inhibitors |
| Title: | Use of Incretins in Diabetic Patients |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Diabetes Mellitus, Type 2 |
| Interventions: | DRUG: DPP-4 inhibitors |
| Outcome Measures: | Primary: Glycated hemoglobin, Percentage, 8 years|Fasting plasma glucose, mg/dl, 8 years|Post-prandial plasma glucose, mg/dl, 8 years | Secondary: Angina pectoris, Percentage, 8 years|Extrasystoles, Percentage, 8 years|Atrial fibrillation, Percentage, 8 years|Fatal myocardial infarction, Percentage, 8 years|Non-fatal myocardial infarction, Percentage, 8 years|Heart failure, Percentage, 8 years|Cardiovascular death, Percentage, 8 years |
| Sponsor/Collaborators: | Sponsor: University of Pavia |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | |
| Enrollment: | 2234 |
| Study Type: | OBSERVATIONAL |
| Study Designs: | Observational Model: |Time Perspective: p |
| Start Date: | 2018-03-27 |
| Completion Date: | 2021-05-30 |
| Results First Posted: | |
| Last Update Posted: | 2022-05-24 |
| Locations: | IRCCS Policlinico San Matteo Foundation, Pavia, Lombardy, 27100, Italy |
| URL: | https://clinicaltrials.gov/show/NCT03486964 |
